CRT translocates to the cell surface, serving as an “eat-me” signal that enhances recognition and uptake by antigen-presenting cells (APCs), particularly dendritic cells (DCs), facilitating efficient cross-presentation of tumor antigens to CD4+ helper T cells and CD8+ cytotoxic T lymphocytes (CTLs) (18). This evidence concerns the gene CD8A and neoplasm.